Valuation: Biocon Limited

Capitalization 62TCr 651.85Cr 553.82Cr 506.84Cr 478.38Cr 892.34Cr 900.21Cr 6.01TCr 2.34TCr 30TCr 2.45TCr 2.39TCr 1,02100Cr P/E ratio 2026 *
107x
P/E ratio 2027 * 41.6x
Enterprise value 72TCr 764.82Cr 649.79Cr 594.67Cr 561.28Cr 1.05TCr 1.06TCr 7.05TCr 2.75TCr 35TCr 2.87TCr 2.81TCr 1,19800Cr EV / Sales 2026 *
4.25x
EV / Sales 2027 * 3.57x
Free-Float
45.88%
Yield 2026 *
0.14%
Yield 2027 * 0.22%
1 day-0.48%
1 week+5.77%
Current month+5.77%
1 month+10.04%
3 months+1.72%
Current year-3.43%
1 week 359.2
Extreme 359.2
396.4
1 month 338
Extreme 338
396.4
Current year 337.7
Extreme 337.7
402.8
1 year 317.9
Extreme 317.9
424.95
3 years 217.5
Extreme 217.5
424.95
5 years 191.55
Extreme 191.55
424.95
10 years 102.08
Extreme 102.0833
487.75
Manager TitleAgeSince
Investor Relations Contact - -
Chief Executive Officer - 01/04/2026
Director of Finance/CFO 48 01/04/2026
Director TitleAgeSince
Director/Board Member 71 01/01/2000
Chairman 73 29/11/1978
Director/Board Member 62 27/07/2018
Change 5d. change 1-year change 3-years change Capi.($)
-0.48%+5.77%+15.31%+54.48% 651.85Cr
-0.06%+0.42%+35.24%+84.59% 4.91TCr
-4.03%-2.51%+80.83%+60.63% 4.77TCr
+1.19%-3.50%+1.46%-10.08% 2.38TCr
-3.48%-23.95%+55.73%+435.39% 2.2TCr
-1.86%-1.15%+41.39%-27.50% 1.73TCr
-6.65%-3.10%+24.45%-38.98% 1.59TCr
-2.83%-1.33%+58.86%+208.05% 1.58TCr
+5.42%+12.19%-24.54%+841.67% 1.4TCr
-1.71%-4.73%+39.31% - 1.33TCr
Average -1.45%-2.33%+32.80%+178.69% 2.25TCr
Weighted average by Cap. -1.67%-3.20%+40.62%+144.92%

Financials

2026 *2027 *
Net sales 17TCr 180.04Cr 152.96Cr 139.99Cr 132.13Cr 246.47Cr 248.64Cr 1.66TCr 647.33Cr 8.17TCr 675.47Cr 661.26Cr 28TCr 20TCr 214.09Cr 181.89Cr 166.46Cr 157.12Cr 293.08Cr 295.66Cr 1.97TCr 769.75Cr 9.71TCr 803.21Cr 786.32Cr 34TCr
Net income 485.83Cr 5.14Cr 4.37Cr 4Cr 3.78Cr 7.04Cr 7.1Cr 47Cr 18Cr 233.36Cr 19Cr 19Cr 805.67Cr 1.39TCr 15Cr 13Cr 11Cr 11Cr 20Cr 20Cr 136.05Cr 53Cr 669.16Cr 55Cr 54Cr 2.31TCr
Net Debt 11TCr 112.96Cr 96Cr 88Cr 83Cr 154.64Cr 156Cr 1.04TCr 406.15Cr 5.12TCr 423.8Cr 414.89Cr 18TCr 11TCr 113.32Cr 96Cr 88Cr 83Cr 155.12Cr 156.49Cr 1.05TCr 407.42Cr 5.14TCr 425.13Cr 416.19Cr 18TCr
Logo Biocon Limited
Biocon Limited is an India-based biopharmaceutical company, engaged in the manufacture of biotechnology products and research services. The Company is in the business of manufacturing active pharmaceutical ingredients (APIs) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases. The Company’s segment includes Generics, Biosimilars, Novel Biologics and Research Services. It focuses on three key therapeutic areas - Oncology, Diabetes, and Immunology. Its APIs portfolio includes cardiovascular, anti-diabetics, immunosuppressants, and specialty molecules. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. Its APIs manufacturing facilities with capabilities in microbial fermentation, downstream process, including chromatographic purification, chemical synthesis, peptide synthesis and Highly Potent APIs (HPAPIs). It has over five facilities in Bangalore, Hyderabad and Visakhapatnam in India.
Employees
16,420
Date Price Change Volume
08/26/08 380.40 -0.48% 56,79,695
07/26/07 382.25 +0.43% 52,29,003
06/26/06 380.60 +3.35% 62,30,919
05/26/05 368.25 +2.12% 26,60,976
04/26/04 360.60 +0.26% 26,08,351
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
380.40INR
Average target price
420.63INR
Spread / Average Target
+10.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIOCON Stock